Ambiq Micro initiated with a Neutral at UBS

UBS initiated coverage of Ambiq Micro (AMBQ) with a Neutral rating and $40 price target The firm says the company’s intellectual property allows workloads to run at much lower power, which is important in the wearables market. However, profitability will take time with Ambiq only turning profitable in 2028, the analyst tells investors in a research note.